332 related articles for article (PubMed ID: 11390513)
1. Eotaxin (CCL11) induces in vivo angiogenic responses by human CCR3+ endothelial cells.
Salcedo R; Young HA; Ponce ML; Ward JM; Kleinman HK; Murphy WJ; Oppenheim JJ
J Immunol; 2001 Jun; 166(12):7571-8. PubMed ID: 11390513
[TBL] [Abstract][Full Text] [Related]
2. Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells.
Cheng SS; Lukacs NW; Kunkel SL
J Immunol; 2002 Mar; 168(6):2887-94. PubMed ID: 11884459
[TBL] [Abstract][Full Text] [Related]
3. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression.
Salcedo R; Ponce ML; Young HA; Wasserman K; Ward JM; Kleinman HK; Oppenheim JJ; Murphy WJ
Blood; 2000 Jul; 96(1):34-40. PubMed ID: 10891427
[TBL] [Abstract][Full Text] [Related]
4. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
Shahabuddin S; Ponath P; Schleimer RP
J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
[TBL] [Abstract][Full Text] [Related]
5. The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells.
Lamkhioued B; Abdelilah SG; Hamid Q; Mansour N; Delespesse G; Renzi PM
J Immunol; 2003 Jan; 170(1):537-47. PubMed ID: 12496441
[TBL] [Abstract][Full Text] [Related]
6. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
[TBL] [Abstract][Full Text] [Related]
7. IL-16 activates plasminogen-plasmin system and promotes human eosinophil migration into extracellular matrix via CCR3-chemokine-mediated signaling and by modulating CD4 eosinophil expression.
Ferland C; Flamand N; Davoine F; Chakir J; Laviolette M
J Immunol; 2004 Oct; 173(7):4417-24. PubMed ID: 15383572
[TBL] [Abstract][Full Text] [Related]
8. Eotaxin activates T cells to chemotaxis and adhesion only if induced to express CCR3 by IL-2 together with IL-4.
Jinquan T; Quan S; Feili G; Larsen CG; Thestrup-Pedersen K
J Immunol; 1999 Apr; 162(7):4285-92. PubMed ID: 10201960
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
Sabroe I; Conroy DM; Gerard NP; Li Y; Collins PD; Post TW; Jose PJ; Williams TJ; Gerard CJ; Ponath PD
J Immunol; 1998 Dec; 161(11):6139-47. PubMed ID: 9834099
[TBL] [Abstract][Full Text] [Related]
10. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
[TBL] [Abstract][Full Text] [Related]
11. CCL11 (Eotaxin) induces CCR3-dependent smooth muscle cell migration.
Kodali RB; Kim WJ; Galaria II; Miller C; Schecter AD; Lira SA; Taubman MB
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1211-6. PubMed ID: 15130922
[TBL] [Abstract][Full Text] [Related]
12. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
Forssmann U; Uguccioni M; Loetscher P; Dahinden CA; Langen H; Thelen M; Baggiolini M
J Exp Med; 1997 Jun; 185(12):2171-6. PubMed ID: 9182688
[TBL] [Abstract][Full Text] [Related]
13. Receptor reserve analysis of the human CCR3 receptor in eosinophils and CCR3-transfected cells.
Umland SP; Wan Y; Shortall J; Shah H; Jakway J; Garlisi CG; Tian F; Egan RW; Billah MM
J Leukoc Biol; 2000 Mar; 67(3):441-7. PubMed ID: 10733106
[TBL] [Abstract][Full Text] [Related]
14. Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo.
Hwang J; Kim CW; Son KN; Han KY; Lee KH; Kleinman HK; Ko J; Na DS; Kwon BS; Gho YS; Kim J
FEBS Lett; 2004 Jul; 570(1-3):47-51. PubMed ID: 15251437
[TBL] [Abstract][Full Text] [Related]
15. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
[TBL] [Abstract][Full Text] [Related]
16. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
Morokata T; Suzuki K; Masunaga Y; Taguchi K; Morihira K; Sato I; Fujii M; Takizawa S; Torii Y; Yamamoto N; Kaneko M; Yamada T; Takahashi K; Shimizu Y
J Pharmacol Exp Ther; 2006 Apr; 317(1):244-50. PubMed ID: 16339911
[TBL] [Abstract][Full Text] [Related]
17. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils.
Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J
J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614
[TBL] [Abstract][Full Text] [Related]
18. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system.
Ferland C; Guilbert M; Davoine F; Flamand N; Chakir J; Laviolette M
J Leukoc Biol; 2001 May; 69(5):772-8. PubMed ID: 11358986
[TBL] [Abstract][Full Text] [Related]
19. Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration.
White JR; Lee JM; Dede K; Imburgia CS; Jurewicz AJ; Chan G; Fornwald JA; Dhanak D; Christmann LT; Darcy MG; Widdowson KL; Foley JJ; Schmidt DB; Sarau HM
J Biol Chem; 2000 Nov; 275(47):36626-31. PubMed ID: 10969084
[TBL] [Abstract][Full Text] [Related]
20. I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo.
Bernardini G; Spinetti G; Ribatti D; Camarda G; Morbidelli L; Ziche M; Santoni A; Capogrossi MC; Napolitano M
Blood; 2000 Dec; 96(13):4039-45. PubMed ID: 11110671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]